Teva Pharmaceutical Industries has announced that its Board of Directors has named Kåre Schultz to become the company’s President and Chief Executive Officer.
Schultz will succeed Dr. Yitzhak Peterburg, who will continue to serve as Interim Chief Executive Officer until Mr. Schultz joins the